Tatva Chintan Pharma Chem Limited (NSE:TATVA)

Tatva Chintan Pharma Chem Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	353.04	273.65	630.17	44.81	108.29
Short-Term Investments	-	3.13	138.5	8.02	8.43	10.92
Trading Asset Securities	-	100.51	-	-	-	-
Cash & Short-Term Investments	148.73	456.68	412.15	638.19	53.24	119.21
Cash Growth	-89.65%	10.80%	-35.42%	1098.70%	-55.34%	-50.91%
Accounts Receivable	-	720.24	875.03	584.27	907.43	495.71
Other Receivables	-	5.18	3.21	27.21	24.95	20.35
Receivables	-	727.83	879.96	613.09	933.57	517.05
Inventory	-	1,528	1,625	1,700	720.19	635.55
Prepaid Expenses	-	55.84	37.1	21.22	15.09	8.16
Other Current Assets	-	211.05	168.31	1,384	120.41	47.02
Total Current Assets	-	2,979	3,123	4,356	1,843	1,327
Property, Plant & Equipment	-	4,995	4,265	2,108	1,302	1,160
Other Intangible Assets	-	39.61	4.76	3.17	0.95	1.2
Long-Term Deferred Tax Assets	-	122.97	164.03	87.1	-	-
Other Long-Term Assets	-	50.92	32.13	26.02	2.96	1.67
Total Assets	-	8,187	7,589	6,581	3,148	2,489
Accounts Payable	-	450.31	321.88	445.13	474.77	292.04
Accrued Expenses	-	87.97	67.46	75.75	60	39.11
Short-Term Debt	-	100	1,562	924.69	492.94	404.89
Current Portion of Long-Term Debt	-	36.32	98.18	143.58	141.91	114.91
Current Income Taxes Payable	-	0.76	2.13	10.23	3.93	-
Current Unearned Revenue	-	21.72	33.12	18.38	0.09	1.46
Other Current Liabilities	-	99.55	302.05	94.2	6.51	24.09
Total Current Liabilities	-	796.63	2,387	1,712	1,180	876.5
Long-Term Debt	-	6.39	42.3	131.11	267.63	387.09
Long-Term Unearned Revenue	-	-	-	0.08	0.17	0.26
Long-Term Deferred Tax Liabilities	-	-	-	-	20.78	44.55
Other Long-Term Liabilities	-	13.34	11.45	6.51	19.66	4.04
Total Liabilities	-	816.36	2,441	1,850	1,488	1,312
Common Stock	-	233.92	221.65	221.65	200.88	80.35
Additional Paid-In Capital	-	4,044	2,090	2,090	-	-
Retained Earnings	-	3,082	2,825	2,415	1,456	1,094
Comprehensive Income & Other	-	10.96	10.75	4.27	2.74	2.48
Shareholders' Equity	7,376	7,371	5,148	4,731	1,660	1,177
Total Liabilities & Equity	-	8,187	7,589	6,581	3,148	2,489
Total Debt	152.31	142.71	1,703	1,199	902.48	906.89
Net Cash (Debt)	-3.58	313.97	-1,290	-561.19	-849.24	-787.68
Net Cash Per Share	-0.15	13.72	-58.22	-26.10	-42.28	-39.21
Filing Date Shares Outstanding	23	23.39	22.17	22.17	20.09	20.09
Total Common Shares Outstanding	23	23.39	22.17	22.17	20.09	20.09
Working Capital	-	2,182	735.59	2,644	662.35	450.49
Book Value Per Share	322.15	315.10	232.25	213.44	82.62	58.59
Tangible Book Value	7,331	7,331	5,143	4,728	1,659	1,176
Tangible Book Value Per Share	320.16	313.41	232.04	213.30	82.57	58.53
Buildings	-	1,544	504.8	376.53	374.45	348.67
Machinery	-	3,005	1,478	1,153	883.5	751.65
Construction In Progress	-	729.27	2,307	514.91	98.11	48.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.